75 related articles for article (PubMed ID: 24072268)
1. Clinical characteristics of breast cancer in patients with an NBS1 mutation.
Huzarski T; Cybulski C; Jakubowska A; Byrski T; Gronwald J; Domagała P; Szwiec M; Godlewski D; Kilar E; Marczyk E; Siołek M; Gorski B; Wiśniowski R; Janiszewska H; Surdyka D; Sibilski R; Sun P; Narod SA; Lubiński J;
Breast Cancer Res Treat; 2013 Oct; 141(3):471-6. PubMed ID: 24072268
[TBL] [Abstract][Full Text] [Related]
2. Survival from breast cancer in patients with CHEK2 mutations.
Huzarski T; Cybulski C; Wokolorczyk D; Jakubowska A; Byrski T; Gronwald J; Domagała P; Szwiec M; Godlewski D; Kilar E; Marczyk E; Siołek M; Wiśniowski R; Janiszewska H; Surdyka D; Sibilski R; Sun P; Lubiński J; Narod SA
Breast Cancer Res Treat; 2014 Apr; 144(2):397-403. PubMed ID: 24557336
[TBL] [Abstract][Full Text] [Related]
3. Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.
Huzarski T; Byrski T; Gronwald J; Górski B; Domagala P; Cybulski C; Oszurek O; Szwiec M; Gugala K; Stawicka M; Morawiec Z; Mierzwa T; Janiszewska H; Kilar E; Marczyk E; Kozak-Klonowska B; Siolek M; Surdyka D; Wisniowski R; Posmyk M; Sun P; Lubinski J; Narod SA
J Clin Oncol; 2013 Sep; 31(26):3191-6. PubMed ID: 23940229
[TBL] [Abstract][Full Text] [Related]
4. I171V germline mutation in the NBS1 gene significantly increases risk of breast cancer.
Roznowski K; Januszkiewicz-Lewandowska D; Mosor M; Pernak M; Litwiniuk M; Nowak J
Breast Cancer Res Treat; 2008 Jul; 110(2):343-8. PubMed ID: 17899368
[TBL] [Abstract][Full Text] [Related]
5. NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Buslov KG; Iyevleva AG; Chekmariova EV; Suspitsin EN; Togo AV; Kuligina ESh; Sokolenko AP; Matsko DE; Turkevich EA; Lazareva YR; Chagunava OL; Bit-Sava EM; Semiglazov VF; Devilee P; Cornelisse C; Hanson KP; Imyanitov EN
Int J Cancer; 2005 Apr; 114(4):585-9. PubMed ID: 15578693
[TBL] [Abstract][Full Text] [Related]
6. Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland.
Steffen J; Nowakowska D; Niwińska A; Czapczak D; Kluska A; Piatkowska M; Wiśniewska A; Paszko Z
Int J Cancer; 2006 Jul; 119(2):472-5. PubMed ID: 16770759
[TBL] [Abstract][Full Text] [Related]
7. Germline 657del5 mutation in the NBS1 gene in breast cancer patients.
Górski B; Debniak T; Masojć B; Mierzejewski M; Medrek K; Cybulski C; Jakubowska A; Kurzawski G; Chosia M; Scott R; Lubiński J
Int J Cancer; 2003 Sep; 106(3):379-81. PubMed ID: 12845677
[TBL] [Abstract][Full Text] [Related]
8. Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy?
Narod SA; Metcalfe K; Lynch HT; Ghadirian P; Robidoux A; Tung N; Gaughan E; Kim-Sing C; Olopade OI; Foulkes WD; Robson M; Offit K; Jakubowska A; Byrski T; Huzarski T; Sun P; Lubinski J
Breast Cancer Res Treat; 2013 Feb; 138(1):273-9. PubMed ID: 23381743
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study.
Goodwin PJ; Phillips KA; West DW; Ennis M; Hopper JL; John EM; O'Malley FP; Milne RL; Andrulis IL; Friedlander ML; Southey MC; Apicella C; Giles GG; Longacre TA
J Clin Oncol; 2012 Jan; 30(1):19-26. PubMed ID: 22147742
[TBL] [Abstract][Full Text] [Related]
11. Body weight correlates with mortality in early-stage breast cancer.
Enger SM; Greif JM; Polikoff J; Press M
Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612
[TBL] [Abstract][Full Text] [Related]
12. Tumour diploidy and survival in breast cancer patients with BRCA2 mutations.
Tryggvadottir L; Olafsdottir EJ; Olafsdottir GH; Sigurdsson H; Johannsson OT; Bjorgvinsson E; Alexiusdottir K; Stefansson OA; Agnarsson BA; Narod SA; Eyfjord JE; Jonasson JG
Breast Cancer Res Treat; 2013 Jul; 140(2):375-84. PubMed ID: 23857704
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy.
Meyer A; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2007 Mar; 82(3):349-53. PubMed ID: 17250914
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk of heterozygotes with the NBN founder mutation.
Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
16. NBS1 variant I171V and breast cancer risk.
Bogdanova N; Schürmann P; Waltes R; Feshchenko S; Zalutsky IV; Bremer M; Dörk T
Breast Cancer Res Treat; 2008 Nov; 112(1):75-9. PubMed ID: 18049891
[TBL] [Abstract][Full Text] [Related]
17. Heterozygous carriers of the I171V mutation of the NBS1 gene have a significantly increased risk of solid malignant tumours.
Nowak J; Mosor M; Ziółkowska I; Wierzbicka M; Pernak-Schwarz M; Przyborska M; Roznowski K; Pławski A; Słomski R; Januszkiewicz D
Eur J Cancer; 2008 Mar; 44(4):627-30. PubMed ID: 18280732
[TBL] [Abstract][Full Text] [Related]
18. Germline NBS1 mutations in families with aggregation of Breast and/or ovarian cancer from north-east Poland.
Kanka C; Brozek I; Skalska B; Siemiatkowska A; Limon J
Anticancer Res; 2007; 27(4C):3015-8. PubMed ID: 17695489
[TBL] [Abstract][Full Text] [Related]
19. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
[TBL] [Abstract][Full Text] [Related]
20. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
